STAAR Surgical Company (STAA): Price and Financial Metrics
STAA Price/Volume Stats
| Current price | $47.82 | 52-week high | $73.13 |
| Prev. close | $48.19 | 52-week low | $26.66 |
| Day low | $47.77 | Volume | 571,200 |
| Day high | $49.13 | Avg. volume | 755,067 |
| 50-day MA | $39.03 | Dividend yield | N/A |
| 200-day MA | $38.91 | Market Cap | 2.34B |
STAA Stock Price Chart Interactive Chart >
STAAR Surgical Company (STAA) Company Bio
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.
Latest STAA News From Around the Web
Below are the latest news stories about STAAR SURGICAL CO that investors may wish to consider to help them evaluate STAA as an investment opportunity.
7 Stocks with Strong Insider Buying: December 2023Stocks with strong insider buying should make you curious, and finding them can be a useful shortcut for your research |
Lululemon Athletica gets one more downgrade ahead of Q3 report: 4 big analyst cutsUnlock the potential of InvestingPro for up to 60% off this Cyber Monday Extended and never miss out on a market winner again. |
Lilian Zhou Appointed to STAAR Surgical Board of DirectorsLAKE FOREST, Calif., December 04, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced the appointment of Lilian Zhou to its Board of Directors, effective December 4, 2023. |
Should Weakness in STAAR Surgical Company's (NASDAQ:STAA) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?With its stock down 18% over the past month, it is easy to disregard STAAR Surgical (NASDAQ:STAA). However, the... |
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)LAKE FOREST, Calif., November 15, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management will participate in the Stephens Annual Investment Conference on Thursday, November 16, 2023. |
STAA Price Returns
| 1-mo | 32.83% |
| 3-mo | 61.72% |
| 6-mo | 24.05% |
| 1-year | -29.26% |
| 3-year | -64.70% |
| 5-year | 45.57% |
| YTD | 53.22% |
| 2023 | -35.70% |
| 2022 | -46.83% |
| 2021 | 15.25% |
| 2020 | 125.25% |
| 2019 | 10.22% |
Continue Researching STAA
Want to do more research on Staar Surgical Co's stock and its price? Try the links below:Staar Surgical Co (STAA) Stock Price | Nasdaq
Staar Surgical Co (STAA) Stock Quote, History and News - Yahoo Finance
Staar Surgical Co (STAA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...